Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 52 Ovarian Neoplasms 4 Neoplasms 3 Inflammatory Breast Neoplasms 3 HER2-positive Breast Cancer 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-Positive Early Breast Cancer 1 HER2 Positive Breast Cancer 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Rituximab 171 Cyclophosphamide 154 fludarabine phosphate 71 Vincristine 71 Etoposide 68 Doxorubicin 67 Prednisone 65 Filgrastim 58 Methotrexate 52 Cytarabine 51 fludarabine 49 Melphalan 48 Busulfan 47 Tacrolimus 41 Whole-Body Irradiation 39 Mycophenolic Acid 39 Granulocyte Colony-Stimulating Factor 37 Antilymphocyte Serum 31 Peripheral Blood Stem Cell Transplantation 30 Radiotherapy 27 Lenalidomide 25 Dexamethasone 25 Carmustine 23 Stem Cell Transplantation 22 Cyclosporine 22 Bortezomib 22 Gemcitabine 20 Bendamustine Hydrochloride 20 Alemtuzumab 19 thymoglobulin 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡